Physician profile
Stephen A Chitty
NPI 1902895824
$29,986.55
in general payments reported to CMS, 2019-2025
68 companies · $4,174 in 2025
The $4,174 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,028 · 2020: $2,090 · 2021: $2,615 · 2022: $9,942 · 2023: $4,009 · 2024: $4,128 · 2025: $4,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $151 · Consulting Fee: $52.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,106.64 |
| Education | $151.37 |
| Consulting Fee | $52.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,274.66 | 2022 | |
| Glaxosmithkline, LLC. | $2,802.74 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $2,736.25 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $2,024.13 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,914.79 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $1,236.07 | 2019-2025 | Xembify, Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,120.85 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Insmed, INC. | $1,098.18 | 2019-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $1,061.66 | 2020-2025 | Acthar, Terlivaz |
| Actelion Pharmaceuticals US, INC. | $862.54 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Mylan Specialty L.P. | $632.12 | 2019-2024 | Yupelri |
| Philips North America LLC | $622.82 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Sunovion Pharmaceuticals INC. | $460.04 | 2019-2021 | |
| Exthera Medical Corporation | $435.17 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $381.12 | 2021-2023 | Ultomiris |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $349.69 | 2022-2025 | Hizentra |
| Amgen INC. | $318.39 | 2022-2025 | Tezspire |
| Pfizer INC. | $311.67 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $299.09 | 2020-2025 | Cuvitru, Glassia |
| Novartis Pharmaceuticals Corporation | $279.96 | 2019-2024 | |
| United Therapeutics Corporation | $256.31 | 2020-2024 | Tyvaso |
| Pulmonx Corporation | $246.69 | 2022-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Octapharma USA, INC. | $223.83 | 2021 | |
| Merck Sharp & Dohme LLC | $217.15 | 2019-2025 | Winrevair |
| Genentech USA, INC. | $215.30 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $207.40 | 2019-2023 | Xywav |
| Harmony Biosciences LLC | $193.13 | 2020-2025 | |
| Ethicon INC. | $180.05 | 2019-2021 | |
| Verona Pharma, INC. | $175.58 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $175.08 | 2019-2024 | |
| Medtronic, INC. | $174.48 | 2021-2024 | Illumisite |
| Abbvie INC. | $169.59 | 2021-2025 | |
| Inogen, INC. | $166.24 | 2022-2025 | Inogen |
| Veran Medical Technologies, INC. | $160.50 | 2019-2021 | |
| Memed US, INC. | $152.82 | 2024 | Memed Bv Calibrator |
| Electromed, INC. | $147.34 | 2019-2025 | Smartvest |
| Adma Biomanufacturing LLC | $140.40 | 2023-2025 | |
| Inspire Medical Systems, INC. | $128.41 | 2022 | |
| Baxter Healthcare | $123.40 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Avadel Cns Pharmaceuticals, LLC | $122.35 | 2023-2025 | Lumryz |
| Allergan, INC. | $116.58 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $107.34 | 2022-2025 | Giapreza |
| Axsome Therapeutics, INC. | $96.12 | 2023-2025 | Sunosi |
| Ani Pharmaceuticals, INC. | $91.61 | 2023-2024 | Purified Cortrophin Gel |
| Janssen Pharmaceuticals, INC | $69.71 | 2019-2024 | Xarelto |
| Viatris Specialty LLC | $68.88 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $58.39 | 2022-2023 | Quviviq |
| Tactile Systems Technology INC | $55.49 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Mallinckrodt Enterprises LLC | $54.01 | 2019 | |
| Ambu INC. | $52.69 | 2021-2023 | |
| Tempus Ai, INC | $49.09 | 2025 | Xt Cdx |
| Seqirus USA INC | $45.28 | 2025 | Flucelvax, Fluad |
| Teva Pharmaceuticals USA, INC. | $37.47 | 2020 | |
| Body Vision Medical INC. | $36.15 | 2023 | Lungvision |
| Johnson & Johnson Health Care Systems INC. | $27.57 | 2023 | Opsumit |
| Olympus America INC. | $20.89 | 2021 | |
| Sanofi Pasteur INC. | $20.59 | 2025 | |
| Shionogi INC | $20.55 | 2025 | Fetroja |
| Boston Scientific Corporation | $20.41 | 2021 | |
| Vanda Pharmaceuticals INC. | $19.09 | 2020 | |
| Paratek Pharmaceuticals, INC. | $17.49 | 2025 | Nuzyra |
| Zoll Respicardia, INC. | $16.06 | 2023 | Remede System |
| Portola Pharmaceuticals, LLC | $15.17 | 2020 | |
| Abiomed | $14.87 | 2020 | |
| Circassia INC. | $14.76 | 2020 | |
| Covidien Lp | $14.49 | 2020 | |
| Optinose US, INC. | $14.12 | 2019 | |
| Fisher & Paykel Healthcare INC | $13.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Chitty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.